The drug, being developed for a rare genetic disorder and currently under review in the U.S., is seen by some investors as ...

Early identification of individuals at a high risk for MASLD could “profoundly transform” intervention strategies, experts say.

Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

The leading Migraine Companies such as ​ Satsuma Pharmaceuticals, Biohaven Pharmaceuticals, Allodynic Therapeutics, Vaxxinity ...